Funding Rounds

Antabio

Antabio Series A (2017, $7M)

Developer of MEM-ANT3310, a next generation antibacterial combination.

View Company Profile

Summary

Stage: Series A

Raised Amount: $7.90M

Investors

BNP Paribas
( 39 )

Omnes Capital
( 30 )

Omnes Capital
( 30 )

IXO Private Equity
( 28 )

Sham Innovation Santé
( 28 )

RDI SORIDEC Gestion
( 21 )

Galia Gestion
( 28 )